08:15 - 09:00

Registration opens

09:00 - 10:30

RAPID-FIRE SESSION

Chairs: Prof Susan Mollan, Birmingham, UK and Kingston, Canada & Prof Rachel Pilling, Bradford, UK

​

#52: Four-Year Outcomes of Faricimab in nAMD: Safety and Tolerability Results From the AVONELLE-X Long-Term Extension Trial

James Talks, Newcastle, UK

​

#53: Two-Year Effectiveness, Durability and Safety of Faricimab in Eyes With DMO: Results From the
UK FARWIDE-DMO Study

Christine Kiire, Oxford, UK

​

#55: Diabetic Retinopathy Screening Outcomes After age 80

Arya Ghatge, Gloucester, UK

​

#41: Automated AI-Based Coregistration Platform for Microperimetry and Optical Coherence Tomography Enables Structure-Function Analysis in Retinal Disease

Vasil Kostin, Oxford, UK

​

#01: Randomised Controlled Trial of Topical Combination Therapy Chlorhexidine 0.2% and Natamycin 5% Versus Topical Natamycin 5% Alone for Fungal Keratitis in East Africa

Jeremy Hoffman, London, UK

​

#32:Improving the Molecular Diagnostic Rate for Developmental Glaucoma in the 100,000 Genomes Project

Nicky Cronbach, London, UK

​

​​#54: Metagenomics for Ocular Inflammation - Initial Insights and Results from a Single-Site UK Study

Daniyal Ansari, Maidstone, UK

​​

#91: Nurse-led Optos Screening for Retinopathy of Prematurity (ROP)

Venughanan Manikavasagar, Derby, UK

​

#84: Patient Reported Outcome Measures 1 Year after Uveal Melanoma Treatment

Catharine Kwok, Watford, UK

#111: Microneedle delivery of stem cell-derived retinal pigment epithelial cells

Jared Ching, Yokohama, Japan. Oxford, UK. Singapore

​

#92: Neurofilament Light Chain as a Biomarker of Treatment Response in Idiopathic Intracranial Hypertension: a Longitudinal Study From the Idiopathic Intracranial Hypertension Weight Trial

Michael Lowe, Birmingham, UK

​

#112: Efficacy of Intra-Retinal Arterial Cannulation for Central Retinal Artery Occlusion with Visible Platelet-Fibrin Emboli

Shin Tanaka, Yokohama, Japan. Oxford, UK

​

#90: Calcitonin Gene-related Peptide Induces Headache Attacks in People With Idiopathic Intracranial Hypertension

Andreas Yiangou, Birmingham, UK​

​​

#110: Primary Results of the Phase 3 SatraGO-1 and SatraGO-2 Trials: Efficacy and Safety of Satralizumab in Thyroid Eye Disease

Daniel G Ezra, London, UK

10:30 - 11:15

Refreshments, Exhibition, Posters

11:15 - 12:30

DOYNE LECTURE: THE LONG VIEW ON SHORT-SIGHT: THE FUTURE OF MYOPIA

​

Lecturer: Prof Chris Hammond, London, UK

Introduction and Doyne Medal presentation: Mr Manoj V. Parulekar, Oxford & Birmingham, UK

12:30 - 14:00

Lunch, Exhibition, Posters

14:00 - 15:30

Letters on a chart mean nothing

Chairs: Mr S. James Talks, Newcastle, UK & Ms Marie Hickey-Dwyer, Limerick, Ireland

Visual impairment and career choice  

Patrick Watts, Cardiff, UK

Visual Field Loss – through the eyes of the patient

David Crabb, London, UK

Visual loss in macular disease

Susan Downes, Oxford, UK

Visual impact of nystagmus

Jay Self, Southampton, UK
 

Vision and driving 

Lauren Hepworth, Liverpool, UK

​

Discussion

Panel Questions  

15:30 - 16:00

Refreshment, Exhibition, Posters

16:00 - 17:15

Focus on surgical techniques

Chairs: Ms Roxane Hillier, Newcastle, UK & Prof Sir Peng T. Khaw, London, UK

​

New strabismus techniques

Saurabh Jain, London, UK

Animal Vision

Jeroen Klevering, Nijmegen, The Netherlands

Management of Eyelid Trauma    

Cornelius René, Cambridge, UK

​

Surgery for sub-macular haemorrhages

Theo Potamitis, Limassol, Cyprus

Optic nerve decompression

Sachin Salvi, Sheffield, UK​

19:00

OOC GALA DINNER

Rhodes House Hall. Drinks from 19:00. Sit down to dinner @ 20:00